nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—melanoma	0.263	1	CbGaD
Toremifene—CYP1A1—Dacarbazine—melanoma	0.126	0.235	CbGbCtD
Toremifene—CYP1A2—Carmustine—melanoma	0.093	0.174	CbGbCtD
Toremifene—CYP1A2—Vemurafenib—melanoma	0.0735	0.137	CbGbCtD
Toremifene—CYP3A4—Temozolomide—melanoma	0.0703	0.131	CbGbCtD
Toremifene—CYP1A2—Dacarbazine—melanoma	0.0564	0.105	CbGbCtD
Toremifene—ABCB1—Dactinomycin—melanoma	0.0427	0.0797	CbGbCtD
Toremifene—CYP3A4—Vemurafenib—melanoma	0.0385	0.0719	CbGbCtD
Toremifene—ABCB1—Docetaxel—melanoma	0.0221	0.0412	CbGbCtD
Toremifene—CYP3A4—Docetaxel—melanoma	0.0132	0.0247	CbGbCtD
Toremifene—Polyp—Vemurafenib—melanoma	0.00335	0.0273	CcSEcCtD
Toremifene—Cyst—Vemurafenib—melanoma	0.00305	0.0248	CcSEcCtD
Toremifene—Paresis—Temozolomide—melanoma	0.00286	0.0232	CcSEcCtD
Toremifene—Thromboembolic event—Docetaxel—melanoma	0.00258	0.0209	CcSEcCtD
Toremifene—Rigors—Vemurafenib—melanoma	0.0025	0.0203	CcSEcCtD
Toremifene—Disorder sight—Temozolomide—melanoma	0.00219	0.0178	CcSEcCtD
Toremifene—Deep vein thrombosis—Temozolomide—melanoma	0.00171	0.0139	CcSEcCtD
Toremifene—Embolism—Temozolomide—melanoma	0.00162	0.0132	CcSEcCtD
Toremifene—Cyst—Carmustine—melanoma	0.00161	0.0131	CcSEcCtD
Toremifene—Thrombosis—Carmustine—melanoma	0.00152	0.0124	CcSEcCtD
Toremifene—Arthritis—Vemurafenib—melanoma	0.00152	0.0124	CcSEcCtD
Toremifene—Vaginal haemorrhage—Temozolomide—melanoma	0.00141	0.0114	CcSEcCtD
Toremifene—Rigors—Temozolomide—melanoma	0.00128	0.0104	CcSEcCtD
Toremifene—Foetor hepaticus—Docetaxel—melanoma	0.00122	0.00993	CcSEcCtD
Toremifene—Polyp—Docetaxel—melanoma	0.00114	0.00926	CcSEcCtD
Toremifene—Deep vein thrombosis—Docetaxel—melanoma	0.00114	0.00926	CcSEcCtD
Toremifene—Neuropathy peripheral—Vemurafenib—melanoma	0.00112	0.00909	CcSEcCtD
Toremifene—Coordination abnormal—Carmustine—melanoma	0.0011	0.00893	CcSEcCtD
Toremifene—Embolism—Docetaxel—melanoma	0.00108	0.00878	CcSEcCtD
Toremifene—Pulmonary embolism—Carmustine—melanoma	0.00108	0.00877	CcSEcCtD
Toremifene—Coordination abnormal—Temozolomide—melanoma	0.00106	0.00863	CcSEcCtD
Toremifene—Pulmonary embolism—Temozolomide—melanoma	0.00104	0.00847	CcSEcCtD
Toremifene—Cyst—Docetaxel—melanoma	0.00104	0.00843	CcSEcCtD
Toremifene—Liver disorder—Docetaxel—melanoma	0.00102	0.00827	CcSEcCtD
Toremifene—Dry eye—Temozolomide—melanoma	0.000963	0.00783	CcSEcCtD
Toremifene—Eye disorder—Vemurafenib—melanoma	0.000958	0.00778	CcSEcCtD
Toremifene—Abnormal vision—Carmustine—melanoma	0.000941	0.00765	CcSEcCtD
Toremifene—Angiopathy—Vemurafenib—melanoma	0.00093	0.00755	CcSEcCtD
Toremifene—Mediastinal disorder—Vemurafenib—melanoma	0.000924	0.0075	CcSEcCtD
Toremifene—Arthritis—Bleomycin—melanoma	0.000923	0.0075	CcSEcCtD
Toremifene—Chills—Vemurafenib—melanoma	0.00092	0.00747	CcSEcCtD
Toremifene—Abnormal vision—Temozolomide—melanoma	0.00091	0.00739	CcSEcCtD
Toremifene—Alopecia—Vemurafenib—melanoma	0.000906	0.00736	CcSEcCtD
Toremifene—Thrombophlebitis—Carmustine—melanoma	0.000905	0.00735	CcSEcCtD
Toremifene—Malnutrition—Vemurafenib—melanoma	0.000892	0.00725	CcSEcCtD
Toremifene—Thrombophlebitis—Temozolomide—melanoma	0.000875	0.00711	CcSEcCtD
Toremifene—Back pain—Vemurafenib—melanoma	0.000863	0.00701	CcSEcCtD
Toremifene—Lethargy—Dactinomycin—melanoma	0.000854	0.00694	CcSEcCtD
Toremifene—Rigors—Docetaxel—melanoma	0.00085	0.0069	CcSEcCtD
Toremifene—Hot flush—Temozolomide—melanoma	0.000809	0.00658	CcSEcCtD
Toremifene—Menopausal symptoms—Temozolomide—melanoma	0.000802	0.00652	CcSEcCtD
Toremifene—Diplopia—Carmustine—melanoma	0.000783	0.00637	CcSEcCtD
Toremifene—Liver function test abnormal—Dactinomycin—melanoma	0.000773	0.00628	CcSEcCtD
Toremifene—Diplopia—Temozolomide—melanoma	0.000757	0.00615	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000754	0.00613	CcSEcCtD
Toremifene—Affect lability—Temozolomide—melanoma	0.000745	0.00605	CcSEcCtD
Toremifene—Ataxia—Carmustine—melanoma	0.000737	0.00599	CcSEcCtD
Toremifene—Liver function test abnormal—Carmustine—melanoma	0.000723	0.00588	CcSEcCtD
Toremifene—Mood swings—Temozolomide—melanoma	0.000717	0.00583	CcSEcCtD
Toremifene—Nervous system disorder—Vemurafenib—melanoma	0.000714	0.0058	CcSEcCtD
Toremifene—Ataxia—Temozolomide—melanoma	0.000712	0.00578	CcSEcCtD
Toremifene—Skin disorder—Vemurafenib—melanoma	0.000707	0.00575	CcSEcCtD
Toremifene—Hepatocellular injury—Docetaxel—melanoma	0.000694	0.00564	CcSEcCtD
Toremifene—Pulmonary embolism—Docetaxel—melanoma	0.000694	0.00564	CcSEcCtD
Toremifene—Breast disorder—Temozolomide—melanoma	0.000684	0.00556	CcSEcCtD
Toremifene—Acute coronary syndrome—Bleomycin—melanoma	0.000682	0.00554	CcSEcCtD
Toremifene—Myocardial infarction—Bleomycin—melanoma	0.000678	0.00551	CcSEcCtD
Toremifene—Decreased appetite—Vemurafenib—melanoma	0.000633	0.00514	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vemurafenib—melanoma	0.000629	0.00511	CcSEcCtD
Toremifene—Fatigue—Vemurafenib—melanoma	0.000628	0.0051	CcSEcCtD
Toremifene—Constipation—Vemurafenib—melanoma	0.000623	0.00506	CcSEcCtD
Toremifene—Weight increased—Temozolomide—melanoma	0.000596	0.00484	CcSEcCtD
Toremifene—Neuropathy peripheral—Carmustine—melanoma	0.000592	0.00481	CcSEcCtD
Toremifene—Thrombophlebitis—Docetaxel—melanoma	0.000582	0.00473	CcSEcCtD
Toremifene—Neuropathy peripheral—Temozolomide—melanoma	0.000572	0.00465	CcSEcCtD
Toremifene—Chills—Bleomycin—melanoma	0.000557	0.00453	CcSEcCtD
Toremifene—Hepatobiliary disease—Temozolomide—melanoma	0.000552	0.00448	CcSEcCtD
Toremifene—Alopecia—Bleomycin—melanoma	0.000549	0.00446	CcSEcCtD
Toremifene—Hot flush—Docetaxel—melanoma	0.000538	0.00437	CcSEcCtD
Toremifene—Menopausal symptoms—Docetaxel—melanoma	0.000534	0.00434	CcSEcCtD
Toremifene—Asthenia—Vemurafenib—melanoma	0.000522	0.00424	CcSEcCtD
Toremifene—Visual impairment—Carmustine—melanoma	0.000522	0.00424	CcSEcCtD
Toremifene—Chills—Dactinomycin—melanoma	0.00052	0.00422	CcSEcCtD
Toremifene—Cardiac failure—Docetaxel—melanoma	0.000516	0.00419	CcSEcCtD
Toremifene—Pruritus—Vemurafenib—melanoma	0.000515	0.00419	CcSEcCtD
Toremifene—Lethargy—Docetaxel—melanoma	0.000514	0.00417	CcSEcCtD
Toremifene—Alopecia—Dactinomycin—melanoma	0.000512	0.00416	CcSEcCtD
Toremifene—Eye disorder—Carmustine—melanoma	0.000506	0.00412	CcSEcCtD
Toremifene—Visual impairment—Temozolomide—melanoma	0.000505	0.0041	CcSEcCtD
Toremifene—Eye disorder—Temozolomide—melanoma	0.000489	0.00398	CcSEcCtD
Toremifene—Arrhythmia—Carmustine—melanoma	0.000484	0.00393	CcSEcCtD
Toremifene—Leukopenia—Bleomycin—melanoma	0.000484	0.00393	CcSEcCtD
Toremifene—Dizziness—Vemurafenib—melanoma	0.000481	0.00391	CcSEcCtD
Toremifene—Alopecia—Carmustine—melanoma	0.000479	0.00389	CcSEcCtD
Toremifene—Angiopathy—Temozolomide—melanoma	0.000475	0.00386	CcSEcCtD
Toremifene—Mental disorder—Carmustine—melanoma	0.000475	0.00386	CcSEcCtD
Toremifene—Ataxia—Docetaxel—melanoma	0.000473	0.00385	CcSEcCtD
Toremifene—Mediastinal disorder—Temozolomide—melanoma	0.000472	0.00384	CcSEcCtD
Toremifene—Malnutrition—Carmustine—melanoma	0.000472	0.00383	CcSEcCtD
Toremifene—Chills—Temozolomide—melanoma	0.00047	0.00382	CcSEcCtD
Toremifene—Liver function test abnormal—Docetaxel—melanoma	0.000465	0.00378	CcSEcCtD
Toremifene—Vomiting—Vemurafenib—melanoma	0.000463	0.00376	CcSEcCtD
Toremifene—Alopecia—Temozolomide—melanoma	0.000463	0.00376	CcSEcCtD
Toremifene—Chest pain—Bleomycin—melanoma	0.00046	0.00374	CcSEcCtD
Toremifene—Rash—Vemurafenib—melanoma	0.000459	0.00373	CcSEcCtD
Toremifene—Mental disorder—Temozolomide—melanoma	0.000459	0.00373	CcSEcCtD
Toremifene—Dermatitis—Vemurafenib—melanoma	0.000459	0.00373	CcSEcCtD
Toremifene—Back pain—Carmustine—melanoma	0.000456	0.00371	CcSEcCtD
Toremifene—Headache—Vemurafenib—melanoma	0.000456	0.00371	CcSEcCtD
Toremifene—Malnutrition—Temozolomide—melanoma	0.000456	0.0037	CcSEcCtD
Toremifene—Breast disorder—Docetaxel—melanoma	0.000455	0.0037	CcSEcCtD
Toremifene—Leukopenia—Dactinomycin—melanoma	0.000451	0.00367	CcSEcCtD
Toremifene—Vision blurred—Carmustine—melanoma	0.000445	0.00361	CcSEcCtD
Toremifene—Tremor—Carmustine—melanoma	0.000442	0.00359	CcSEcCtD
Toremifene—Oedema—Bleomycin—melanoma	0.000441	0.00358	CcSEcCtD
Toremifene—Back pain—Temozolomide—melanoma	0.000441	0.00358	CcSEcCtD
Toremifene—Nausea—Vemurafenib—melanoma	0.000432	0.00351	CcSEcCtD
Toremifene—Thrombocytopenia—Bleomycin—melanoma	0.000432	0.00351	CcSEcCtD
Toremifene—Vision blurred—Temozolomide—melanoma	0.00043	0.00349	CcSEcCtD
Toremifene—Tremor—Temozolomide—melanoma	0.000427	0.00347	CcSEcCtD
Toremifene—Angina pectoris—Docetaxel—melanoma	0.000424	0.00344	CcSEcCtD
Toremifene—Leukopenia—Carmustine—melanoma	0.000422	0.00343	CcSEcCtD
Toremifene—Anorexia—Bleomycin—melanoma	0.00042	0.00342	CcSEcCtD
Toremifene—Oedema—Dactinomycin—melanoma	0.000411	0.00334	CcSEcCtD
Toremifene—Vertigo—Temozolomide—melanoma	0.00041	0.00333	CcSEcCtD
Toremifene—Leukopenia—Temozolomide—melanoma	0.000408	0.00332	CcSEcCtD
Toremifene—Thrombocytopenia—Dactinomycin—melanoma	0.000403	0.00327	CcSEcCtD
Toremifene—Chest pain—Carmustine—melanoma	0.000402	0.00326	CcSEcCtD
Toremifene—Weight increased—Docetaxel—melanoma	0.000396	0.00322	CcSEcCtD
Toremifene—Dyspnoea—Bleomycin—melanoma	0.000393	0.0032	CcSEcCtD
Toremifene—Anorexia—Dactinomycin—melanoma	0.000392	0.00319	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000385	0.00313	CcSEcCtD
Toremifene—Oedema—Carmustine—melanoma	0.000385	0.00313	CcSEcCtD
Toremifene—Decreased appetite—Bleomycin—melanoma	0.000383	0.00312	CcSEcCtD
Toremifene—Acute coronary syndrome—Docetaxel—melanoma	0.000382	0.00311	CcSEcCtD
Toremifene—Myocardial infarction—Docetaxel—melanoma	0.00038	0.00309	CcSEcCtD
Toremifene—Neuropathy peripheral—Docetaxel—melanoma	0.00038	0.00309	CcSEcCtD
Toremifene—Jaundice—Docetaxel—melanoma	0.000378	0.00307	CcSEcCtD
Toremifene—Pain—Bleomycin—melanoma	0.000377	0.00306	CcSEcCtD
Toremifene—Thrombocytopenia—Carmustine—melanoma	0.000377	0.00306	CcSEcCtD
Toremifene—Oedema—Temozolomide—melanoma	0.000372	0.00302	CcSEcCtD
Toremifene—Anorexia—Carmustine—melanoma	0.000367	0.00298	CcSEcCtD
Toremifene—Hepatobiliary disease—Docetaxel—melanoma	0.000367	0.00298	CcSEcCtD
Toremifene—Nervous system disorder—Temozolomide—melanoma	0.000365	0.00296	CcSEcCtD
Toremifene—Thrombocytopenia—Temozolomide—melanoma	0.000364	0.00296	CcSEcCtD
Toremifene—Skin disorder—Temozolomide—melanoma	0.000361	0.00294	CcSEcCtD
Toremifene—Hyperhidrosis—Temozolomide—melanoma	0.00036	0.00292	CcSEcCtD
Toremifene—Decreased appetite—Dactinomycin—melanoma	0.000358	0.00291	CcSEcCtD
Toremifene—Fatigue—Dactinomycin—melanoma	0.000355	0.00288	CcSEcCtD
Toremifene—Anorexia—Temozolomide—melanoma	0.000355	0.00288	CcSEcCtD
Toremifene—Pain—Dactinomycin—melanoma	0.000352	0.00286	CcSEcCtD
Toremifene—Insomnia—Carmustine—melanoma	0.000348	0.00283	CcSEcCtD
Toremifene—Dyspnoea—Carmustine—melanoma	0.000343	0.00279	CcSEcCtD
Toremifene—Insomnia—Temozolomide—melanoma	0.000337	0.00273	CcSEcCtD
Toremifene—Visual impairment—Docetaxel—melanoma	0.000336	0.00273	CcSEcCtD
Toremifene—Decreased appetite—Carmustine—melanoma	0.000335	0.00272	CcSEcCtD
Toremifene—Gastrointestinal disorder—Carmustine—melanoma	0.000332	0.0027	CcSEcCtD
Toremifene—Dyspnoea—Temozolomide—melanoma	0.000332	0.0027	CcSEcCtD
Toremifene—Pain—Carmustine—melanoma	0.000329	0.00268	CcSEcCtD
Toremifene—Constipation—Carmustine—melanoma	0.000329	0.00268	CcSEcCtD
Toremifene—Eye disorder—Docetaxel—melanoma	0.000325	0.00264	CcSEcCtD
Toremifene—Decreased appetite—Temozolomide—melanoma	0.000323	0.00263	CcSEcCtD
Toremifene—Gastrointestinal disorder—Temozolomide—melanoma	0.000321	0.00261	CcSEcCtD
Toremifene—Fatigue—Temozolomide—melanoma	0.000321	0.00261	CcSEcCtD
Toremifene—Constipation—Temozolomide—melanoma	0.000318	0.00259	CcSEcCtD
Toremifene—Pain—Temozolomide—melanoma	0.000318	0.00259	CcSEcCtD
Toremifene—Asthenia—Bleomycin—melanoma	0.000316	0.00257	CcSEcCtD
Toremifene—Angiopathy—Docetaxel—melanoma	0.000316	0.00257	CcSEcCtD
Toremifene—Mediastinal disorder—Docetaxel—melanoma	0.000314	0.00255	CcSEcCtD
Toremifene—Chills—Docetaxel—melanoma	0.000313	0.00254	CcSEcCtD
Toremifene—Pruritus—Bleomycin—melanoma	0.000312	0.00254	CcSEcCtD
Toremifene—Arrhythmia—Docetaxel—melanoma	0.000311	0.00253	CcSEcCtD
Toremifene—Alopecia—Docetaxel—melanoma	0.000308	0.0025	CcSEcCtD
Toremifene—Mental disorder—Docetaxel—melanoma	0.000305	0.00248	CcSEcCtD
Toremifene—Malnutrition—Docetaxel—melanoma	0.000303	0.00246	CcSEcCtD
Toremifene—Asthenia—Dactinomycin—melanoma	0.000295	0.0024	CcSEcCtD
Toremifene—Back pain—Docetaxel—melanoma	0.000293	0.00238	CcSEcCtD
Toremifene—Vomiting—Bleomycin—melanoma	0.00028	0.00228	CcSEcCtD
Toremifene—Rash—Bleomycin—melanoma	0.000278	0.00226	CcSEcCtD
Toremifene—Dermatitis—Bleomycin—melanoma	0.000278	0.00226	CcSEcCtD
Toremifene—Asthenia—Carmustine—melanoma	0.000276	0.00224	CcSEcCtD
Toremifene—Leukopenia—Docetaxel—melanoma	0.000271	0.00221	CcSEcCtD
Toremifene—Asthenia—Temozolomide—melanoma	0.000267	0.00217	CcSEcCtD
Toremifene—Pruritus—Temozolomide—melanoma	0.000263	0.00214	CcSEcCtD
Toremifene—Nausea—Bleomycin—melanoma	0.000262	0.00213	CcSEcCtD
Toremifene—Vomiting—Dactinomycin—melanoma	0.000262	0.00213	CcSEcCtD
Toremifene—Rash—Dactinomycin—melanoma	0.000259	0.00211	CcSEcCtD
Toremifene—Chest pain—Docetaxel—melanoma	0.000258	0.0021	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000256	0.00208	CcSEcCtD
Toremifene—Dizziness—Carmustine—melanoma	0.000255	0.00207	CcSEcCtD
Toremifene—Oedema—Docetaxel—melanoma	0.000247	0.00201	CcSEcCtD
Toremifene—Dizziness—Temozolomide—melanoma	0.000246	0.002	CcSEcCtD
Toremifene—Vomiting—Carmustine—melanoma	0.000245	0.00199	CcSEcCtD
Toremifene—Nausea—Dactinomycin—melanoma	0.000244	0.00199	CcSEcCtD
Toremifene—Rash—Carmustine—melanoma	0.000243	0.00197	CcSEcCtD
Toremifene—Nervous system disorder—Docetaxel—melanoma	0.000243	0.00197	CcSEcCtD
Toremifene—Dermatitis—Carmustine—melanoma	0.000243	0.00197	CcSEcCtD
Toremifene—Thrombocytopenia—Docetaxel—melanoma	0.000242	0.00197	CcSEcCtD
Toremifene—Headache—Carmustine—melanoma	0.000241	0.00196	CcSEcCtD
Toremifene—Skin disorder—Docetaxel—melanoma	0.00024	0.00195	CcSEcCtD
Toremifene—Vomiting—Temozolomide—melanoma	0.000237	0.00192	CcSEcCtD
Toremifene—Anorexia—Docetaxel—melanoma	0.000236	0.00192	CcSEcCtD
Toremifene—Rash—Temozolomide—melanoma	0.000235	0.00191	CcSEcCtD
Toremifene—Dermatitis—Temozolomide—melanoma	0.000234	0.0019	CcSEcCtD
Toremifene—Headache—Temozolomide—melanoma	0.000233	0.00189	CcSEcCtD
Toremifene—Nausea—Carmustine—melanoma	0.000229	0.00186	CcSEcCtD
Toremifene—Insomnia—Docetaxel—melanoma	0.000224	0.00182	CcSEcCtD
Toremifene—Nausea—Temozolomide—melanoma	0.000221	0.0018	CcSEcCtD
Toremifene—Dyspnoea—Docetaxel—melanoma	0.000221	0.00179	CcSEcCtD
Toremifene—Decreased appetite—Docetaxel—melanoma	0.000215	0.00175	CcSEcCtD
Toremifene—Gastrointestinal disorder—Docetaxel—melanoma	0.000214	0.00174	CcSEcCtD
Toremifene—Fatigue—Docetaxel—melanoma	0.000213	0.00173	CcSEcCtD
Toremifene—Constipation—Docetaxel—melanoma	0.000212	0.00172	CcSEcCtD
Toremifene—Pain—Docetaxel—melanoma	0.000212	0.00172	CcSEcCtD
Toremifene—Asthenia—Docetaxel—melanoma	0.000178	0.00144	CcSEcCtD
Toremifene—Pruritus—Docetaxel—melanoma	0.000175	0.00142	CcSEcCtD
Toremifene—Orphenadrine—SCN10A—melanoma	0.000173	0.355	CrCbGaD
Toremifene—Dizziness—Docetaxel—melanoma	0.000164	0.00133	CcSEcCtD
Toremifene—Vomiting—Docetaxel—melanoma	0.000157	0.00128	CcSEcCtD
Toremifene—Rash—Docetaxel—melanoma	0.000156	0.00127	CcSEcCtD
Toremifene—Dermatitis—Docetaxel—melanoma	0.000156	0.00127	CcSEcCtD
Toremifene—Headache—Docetaxel—melanoma	0.000155	0.00126	CcSEcCtD
Toremifene—Nausea—Docetaxel—melanoma	0.000147	0.00119	CcSEcCtD
Toremifene—Tamoxifen—CYP1B1—melanoma	0.000136	0.28	CrCbGaD
Toremifene—Clomifene—ABCB1—melanoma	8.45e-05	0.174	CrCbGaD
Toremifene—Loperamide—ABCB1—melanoma	5.44e-05	0.112	CrCbGaD
Toremifene—Tamoxifen—ABCB1—melanoma	3.91e-05	0.0802	CrCbGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.56e-05	0.000328	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HDAC6—melanoma	2.54e-05	0.000325	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACER3—melanoma	2.53e-05	0.000325	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SDHD—melanoma	2.51e-05	0.000322	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CSPG4—melanoma	2.51e-05	0.000322	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BSG—melanoma	2.51e-05	0.000322	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC6A11—melanoma	2.49e-05	0.00032	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIP4K2A—melanoma	2.49e-05	0.00032	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPAM—melanoma	2.44e-05	0.000312	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.43e-05	0.000312	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.43e-05	0.000312	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTAP—melanoma	2.42e-05	0.000311	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.42e-05	0.000311	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCR2—melanoma	2.41e-05	0.000309	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.37e-05	0.000304	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAC2—melanoma	2.37e-05	0.000304	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—WNT5A—melanoma	2.33e-05	0.000299	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFC—melanoma	2.33e-05	0.000299	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UGT2B10—melanoma	2.32e-05	0.000297	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.31e-05	0.000296	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.29e-05	0.000293	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.25e-05	0.000288	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.23e-05	0.000287	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.23e-05	0.000286	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.22e-05	0.000285	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CDKN2B—melanoma	2.16e-05	0.000277	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PHGDH—melanoma	2.16e-05	0.000277	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LUM—melanoma	2.16e-05	0.000277	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HS3ST5—melanoma	2.15e-05	0.000276	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HPSE—melanoma	2.12e-05	0.000272	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLCB4—melanoma	2.12e-05	0.000271	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—VDR—melanoma	2.11e-05	0.00027	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CUBN—melanoma	2.08e-05	0.000267	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.08e-05	0.000266	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLA2G6—melanoma	2.07e-05	0.000266	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2R—melanoma	2.05e-05	0.000262	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.01e-05	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SDHD—melanoma	2.01e-05	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CSPG4—melanoma	2.01e-05	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BSG—melanoma	2.01e-05	0.000258	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIP4K2A—melanoma	1.99e-05	0.000255	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC6A11—melanoma	1.99e-05	0.000255	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDNRB—melanoma	1.98e-05	0.000254	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPAM—melanoma	1.95e-05	0.000249	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PRKCA—melanoma	1.94e-05	0.000249	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTAP—melanoma	1.93e-05	0.000248	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—ERCC2—melanoma	1.93e-05	0.000247	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTK2B—melanoma	1.92e-05	0.000247	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.91e-05	0.000244	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.89e-05	0.000243	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GAB2—melanoma	1.87e-05	0.00024	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNA11—melanoma	1.87e-05	0.00024	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FLT1—melanoma	1.86e-05	0.000239	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—VCAN—melanoma	1.86e-05	0.000239	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.85e-05	0.000238	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.81e-05	0.000232	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.81e-05	0.000232	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.76e-05	0.000226	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FOXO4—melanoma	1.76e-05	0.000226	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCR4—melanoma	1.76e-05	0.000226	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HDAC2—melanoma	1.76e-05	0.000226	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—melanoma	1.74e-05	0.000223	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNAQ—melanoma	1.74e-05	0.000223	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.73e-05	0.000221	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PHGDH—melanoma	1.72e-05	0.000221	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LUM—melanoma	1.72e-05	0.000221	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.71e-05	0.00022	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.7e-05	0.000218	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HPSE—melanoma	1.69e-05	0.000217	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CUBN—melanoma	1.66e-05	0.000213	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLA2G6—melanoma	1.65e-05	0.000212	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SYK—melanoma	1.64e-05	0.00021	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLCB4—melanoma	1.63e-05	0.000209	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT3—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ITGAV—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGFR—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SDHD—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BSG—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CSPG4—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.57e-05	0.000202	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP17A1—melanoma	1.57e-05	0.000201	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH1—melanoma	1.56e-05	0.0002	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPAM—melanoma	1.55e-05	0.000199	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.55e-05	0.000199	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC6A11—melanoma	1.54e-05	0.000197	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIP4K2A—melanoma	1.54e-05	0.000197	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.53e-05	0.000196	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.52e-05	0.000195	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTAP—melanoma	1.49e-05	0.000192	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SOCS1—melanoma	1.49e-05	0.000191	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—VCAN—melanoma	1.49e-05	0.000191	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—S100B—melanoma	1.48e-05	0.00019	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNA11—melanoma	1.48e-05	0.00019	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—melanoma	1.47e-05	0.000188	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—FASN—melanoma	1.45e-05	0.000186	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC5A5—melanoma	1.43e-05	0.000183	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB4—melanoma	1.42e-05	0.000182	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—melanoma	1.41e-05	0.00018	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNAQ—melanoma	1.38e-05	0.000177	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD44—melanoma	1.38e-05	0.000177	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD86—melanoma	1.36e-05	0.000174	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.35e-05	0.000173	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—melanoma	1.35e-05	0.000173	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.34e-05	0.000171	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PHGDH—melanoma	1.33e-05	0.000171	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LUM—melanoma	1.33e-05	0.000171	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP1B1—melanoma	1.32e-05	0.000169	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLA2G6—melanoma	1.32e-05	0.000169	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CSF2—melanoma	1.32e-05	0.000169	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF1—melanoma	1.32e-05	0.000169	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HPSE—melanoma	1.31e-05	0.000167	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—E2F1—melanoma	1.29e-05	0.000165	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.29e-05	0.000165	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CUBN—melanoma	1.28e-05	0.000164	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFRA—melanoma	1.28e-05	0.000164	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ITGB3—melanoma	1.26e-05	0.000162	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCA—melanoma	1.26e-05	0.000162	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP17A1—melanoma	1.25e-05	0.000161	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—melanoma	1.24e-05	0.000159	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SDHD—melanoma	1.24e-05	0.000159	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BSG—melanoma	1.24e-05	0.000159	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CSPG4—melanoma	1.24e-05	0.000159	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAP2K2—melanoma	1.24e-05	0.000158	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPAM—melanoma	1.2e-05	0.000154	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—VCAN—melanoma	1.19e-05	0.000152	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNA11—melanoma	1.18e-05	0.000152	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—melanoma	1.17e-05	0.000151	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAC1—melanoma	1.17e-05	0.00015	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.17e-05	0.00015	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.16e-05	0.000149	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FASN—melanoma	1.16e-05	0.000149	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC5A5—melanoma	1.14e-05	0.000146	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNAQ—melanoma	1.1e-05	0.000141	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD44—melanoma	1.1e-05	0.000141	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—melanoma	1.09e-05	0.00014	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.08e-05	0.000139	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—melanoma	1.07e-05	0.000138	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1B1—melanoma	1.06e-05	0.000135	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FN1—melanoma	1.03e-05	0.000133	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G6—melanoma	1.02e-05	0.000131	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—melanoma	1.01e-05	0.00013	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PRKCA—melanoma	1e-05	0.000128	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP17A1—melanoma	1e-05	0.000128	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ERCC2—melanoma	9.93e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD80—melanoma	9.92e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—melanoma	9.9e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—melanoma	9.9e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KIT—melanoma	9.9e-06	0.000127	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.87e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGF—melanoma	9.78e-06	0.000125	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	9.74e-06	0.000125	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNA11—melanoma	9.45e-06	0.000121	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—melanoma	9.3e-06	0.000119	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FASN—melanoma	9.25e-06	0.000119	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—VCAN—melanoma	9.15e-06	0.000117	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC5A5—melanoma	9.1e-06	0.000117	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—melanoma	9.06e-06	0.000116	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNAQ—melanoma	8.78e-06	0.000113	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD44—melanoma	8.78e-06	0.000113	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAP2K1—melanoma	8.76e-06	0.000112	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—melanoma	8.7e-06	0.000112	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—melanoma	8.61e-06	0.00011	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.6e-06	0.00011	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.52e-06	0.000109	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1B1—melanoma	8.42e-06	0.000108	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—melanoma	8.38e-06	0.000107	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF2—melanoma	8.33e-06	0.000107	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.22e-06	0.000105	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PRKCA—melanoma	8e-06	0.000103	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ERCC2—melanoma	7.93e-06	0.000102	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—melanoma	7.84e-06	0.000101	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDM2—melanoma	7.79e-06	0.0001	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP17A1—melanoma	7.72e-06	9.9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB2—melanoma	7.69e-06	9.86e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—melanoma	7.58e-06	9.73e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—melanoma	7.57e-06	9.71e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.43e-06	9.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNA11—melanoma	7.29e-06	9.35e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—melanoma	7.29e-06	9.35e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FASN—melanoma	7.14e-06	9.15e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—melanoma	7.12e-06	9.13e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A5—melanoma	7.02e-06	9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—melanoma	6.98e-06	8.95e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—melanoma	6.97e-06	8.93e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—melanoma	6.94e-06	8.9e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—melanoma	6.89e-06	8.84e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—melanoma	6.8e-06	8.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—melanoma	6.79e-06	8.71e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNAQ—melanoma	6.78e-06	8.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD44—melanoma	6.78e-06	8.7e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CTNNB1—melanoma	6.72e-06	8.62e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—melanoma	6.59e-06	8.45e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—melanoma	6.57e-06	8.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—melanoma	6.55e-06	8.4e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKB1—melanoma	6.52e-06	8.36e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1B1—melanoma	6.5e-06	8.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PRKCA—melanoma	6.38e-06	8.19e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ERCC2—melanoma	6.33e-06	8.12e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—melanoma	6.26e-06	8.03e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—melanoma	6.04e-06	7.75e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—melanoma	6.01e-06	7.71e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—melanoma	5.95e-06	7.64e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—melanoma	5.92e-06	7.59e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—melanoma	5.86e-06	7.52e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRAS—melanoma	5.85e-06	7.5e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—melanoma	5.81e-06	7.45e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—melanoma	5.6e-06	7.18e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—melanoma	5.51e-06	7.06e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—melanoma	5.45e-06	6.98e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—melanoma	5.44e-06	6.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—melanoma	5.35e-06	6.86e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK1—melanoma	5.33e-06	6.83e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—melanoma	5.33e-06	6.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.24e-06	6.73e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—melanoma	5.19e-06	6.66e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—melanoma	5.03e-06	6.45e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—melanoma	5e-06	6.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PRKCA—melanoma	4.93e-06	6.32e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ERCC2—melanoma	4.89e-06	6.27e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—melanoma	4.83e-06	6.19e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—melanoma	4.8e-06	6.15e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—melanoma	4.75e-06	6.1e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—melanoma	4.62e-06	5.93e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—melanoma	4.47e-06	5.74e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—melanoma	4.4e-06	5.64e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—melanoma	4.34e-06	5.56e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—melanoma	4.28e-06	5.49e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—melanoma	4.15e-06	5.32e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—melanoma	4.09e-06	5.25e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—melanoma	3.86e-06	4.95e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—melanoma	3.83e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—melanoma	3.8e-06	4.87e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—melanoma	3.78e-06	4.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—melanoma	3.72e-06	4.78e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—melanoma	3.66e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—melanoma	3.39e-06	4.35e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—melanoma	3.35e-06	4.29e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—melanoma	3.31e-06	4.25e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—melanoma	2.99e-06	3.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—melanoma	2.96e-06	3.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—melanoma	2.93e-06	3.76e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—melanoma	2.93e-06	3.75e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—melanoma	2.55e-06	3.28e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—melanoma	2.39e-06	3.06e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—melanoma	2.34e-06	3e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—melanoma	1.91e-06	2.45e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—melanoma	1.8e-06	2.31e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—melanoma	1.47e-06	1.89e-05	CbGpPWpGaD
